{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T04:01:06Z","timestamp":1749355266868,"version":"3.41.0"},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,6,1]]},"DOI":"10.2169\/internalmedicine.4201-24","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T22:11:45Z","timestamp":1731017505000},"page":"1750-1755","source":"Crossref","is-referenced-by-count":0,"title":["Anti-OJ Antibody-positive Antisynthetase Myopathy Diagnosed after Pulmonary Embolization"],"prefix":"10.2169","volume":"64","author":[{"given":"Yu","family":"Nakanishi","sequence":"first","affiliation":[{"name":"Department of Respiratory Internal Medicine, Onomichi General Hospital, Japan"},{"name":"Department of Respiratory Internal Medicine, Hiroshima City North Medical Center Asa Citizens Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Onomichi General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Tsuyuki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Mihara Medical Association Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mako","family":"Tsuyuki","sequence":"additional","affiliation":[{"name":"Department of Respiratory Internal Medicine, Onomichi General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Kakumoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Internal Medicine, Onomichi General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Respiratory Internal Medicine, Onomichi General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Hamai","sequence":"additional","affiliation":[{"name":"Department of Respiratory Internal Medicine, Onomichi General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"doi-asserted-by":"crossref","unstructured":"1. Raskob GE, Angchaisuksiri P, Blanco AN, et al. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol 34: 2363-2371, 2014.","key":"1","DOI":"10.1161\/ATVBAHA.114.304488"},{"doi-asserted-by":"crossref","unstructured":"2. Li Y, Wang P, Li L, Wang F, Liu Y. Increased risk of venous thromboembolism associated with polymyositis and dermatomyositis: a meta-analysis. Ther Clin Risk Manag 14: 157-165, 2018.","key":"2","DOI":"10.2147\/TCRM.S157085"},{"doi-asserted-by":"crossref","unstructured":"3. Carruthers EC, Choi HK, Sayre EC, Avi\u00f1a-Zubieta JA. Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study. Ann Rheum Dis 75: 110-116, 2016.","key":"3","DOI":"10.1136\/annrheumdis-2014-205800"},{"doi-asserted-by":"crossref","unstructured":"4. Norimatsu Y, Matsuda KM, Yamaguchi K, et al. The autoantibody array assay: a novel autoantibody detection method. Diagnostics (Basel) 13: 2929, 2023.","key":"4","DOI":"10.3390\/diagnostics13182929"},{"doi-asserted-by":"crossref","unstructured":"5. Kuzumi A, Norimatsu Y, Matsuda KM, et al. Comprehensive autoantibody profiling in systemic autoimmunity by a highly-sensitive multiplex protein array. Front Immunol 14: 1255540, 2023.","key":"5","DOI":"10.3389\/fimmu.2023.1255540"},{"doi-asserted-by":"crossref","unstructured":"6. Pujades-Rodriguez M, Duyx B, Thomas SL, et al. Rheumatoid arthritis and incidence of twelve initial presentations of cardiovascular disease: a population record-linkage cohort study in England. PLoS One 11: e0151245, 2016.","key":"6","DOI":"10.1371\/journal.pone.0151245"},{"doi-asserted-by":"crossref","unstructured":"7. Nowak B, Madej M, \u0141uczak A, Ma\u0142ecki R, Wiland P. Disease activity, oxidized-LDL fraction and anti-oxidized LDL antibodies influence cardiovascular risk in rheumatoid arthritis. Adv Clin Exp Med 25: 43-50, 2016.","key":"7","DOI":"10.17219\/acem\/29847"},{"doi-asserted-by":"crossref","unstructured":"8. Gu\u015fetu G, Pop D, Pamfil C, et al. Subclinical myocardial impairment in SLE: insights from novel ultrasound techniques and clinical determinants. Med Ultrason 18: 47-56, 2016.","key":"8","DOI":"10.11152\/mu.2013.2066.181.zdr"},{"doi-asserted-by":"crossref","unstructured":"9. Tselios K, Sheane BJ, Gladman DD, Urowitz MB. Optimal monitoring for coronary heart disease risk in patients with systemic lupus erythematosus: a systematic review. J Rheumatol 43: 54-65, 2016.","key":"9","DOI":"10.3899\/jrheum.150460"},{"doi-asserted-by":"crossref","unstructured":"10. Haroon NN, Paterson JM, Li P, Inman RD, Haroon N. Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study. Ann Intern Med 163: 409-416, 2015.","key":"10","DOI":"10.7326\/M14-2470"},{"doi-asserted-by":"crossref","unstructured":"11. Heslinga SC, Van den Oever IA, Van Sijl AM, et al. Cardiovascular risk management in patients with active ankylosing spondylitis: a detailed evaluation. BMC Musculoskelet Disord 16: 80, 2015.","key":"11","DOI":"10.1186\/s12891-015-0532-3"},{"doi-asserted-by":"crossref","unstructured":"12. Man A, Zhu Y, Zhang Y, et al. The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study. Ann Rheum Dis 72: 1188-1193, 2013.","key":"12","DOI":"10.1136\/annrheumdis-2012-202007"},{"doi-asserted-by":"crossref","unstructured":"13. Bleau N, Patenaude V, Abenhaim HA. Risk of venous thromboembolic events in pregnant patients with autoimmune diseases: a population-based study. Clin Appl Thromb Hemost 22: 285-291, 2016.","key":"13","DOI":"10.1177\/1076029614553023"},{"unstructured":"14. Z\u00f6ller B, Li X, Sundquist J, Sundquist K. Autoimmune diseases and venous thromboembolism: a review of the literature. Am J Cardiovasc Dis 2: 171-183, 2012.","key":"14"},{"doi-asserted-by":"crossref","unstructured":"15. Choi HK, Rho YH, Zhu Y, Cea-Soriano L, Avi\u00f1a-Zubieta JA, Zhang Y. The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study. Ann Rheum Dis 72: 1182-1187, 2013.","key":"15","DOI":"10.1136\/annrheumdis-2012-201669"},{"doi-asserted-by":"publisher","unstructured":"16. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 362: 971-982, 2003.","key":"16","DOI":"10.1016\/S0140-6736(03)14368-1"},{"doi-asserted-by":"crossref","unstructured":"17. Vege A, Beery J, Kara A. Antisynthetase syndrome in a patient with pulmonary embolism and nonbacterial thrombotic endocarditis. Case Rep Rheumatol 2023: 9068597, 2023.","key":"17","DOI":"10.1155\/2023\/9068597"},{"doi-asserted-by":"crossref","unstructured":"18. Eltelbany M, Huang Y, Sandhu P, et al. Anti-synthetase syndrome in a patient with recurrent episodes of pulmonary embolism: a case report. J Community Hosp Intern Med Perspect 10: 255-257, 2020.","key":"18","DOI":"10.1080\/20009666.2020.1769421"},{"unstructured":"19. Sholter DE, Armstrong PW. Adverse effects of corticosteroids on the cardiovascular system. Can J Cardiol 16: 505-511, 2000.","key":"19"},{"unstructured":"20. Raynauld JP. Cardiovascular mortality in rheumatoid arthritis: how harmful are corticosteroids. J Rheumatol 24: 415-416, 1997.","key":"20"},{"doi-asserted-by":"crossref","unstructured":"21. Jiang M, Dong X, Zheng Y. Clinical characteristics of interstitial lung diseases positive to different anti-synthetase antibodies. Medicine (Baltimore) 100: e25816, 2021.","key":"21","DOI":"10.1097\/MD.0000000000025816"},{"doi-asserted-by":"crossref","unstructured":"22. Kunimasa K, Arita M, Nakazawa T, et al. The clinical characteristics of two anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibody-positive interstitial lung disease patients with polymyositis\/dermatomyositis. Intern Med 51: 3405-3410, 2012.","key":"22","DOI":"10.2169\/internalmedicine.51.7452"},{"doi-asserted-by":"crossref","unstructured":"23. Sato S, Kuwana M, Hirakata M. Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies. Rheumatology (Oxford) 46: 842-845, 2007.","key":"23","DOI":"10.1093\/rheumatology\/kel435"},{"doi-asserted-by":"crossref","unstructured":"24. Suzuki S. Antisynthetase myopathy. Rinsho Shinkeigaku (Clin Neurol) 60: 175-180, 2020 (in Japanese).","key":"24","DOI":"10.5692\/clinicalneurol.cn-001383"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/11\/64_4201-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T04:38:46Z","timestamp":1749271126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/11\/64_4201-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4201-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,6,1]]},"article-number":"4201-24"}}